Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Aug 13 2020

Full Issue

Latest On Vaccines: Global Trials, Concerns For Patients Who Are Obese

Large-scale testing is underway in parts of California and Oregon. Other news on vaccines is on concerns about effectiveness in people who are obese, kids missing routine vaccines and anti-vaxxers' social media campaigns.

San Francisco Chronicle: Bay Area Kaiser Sites To Join One Of First Global Coronavirus Vaccine Trials 

Kaiser Permanente in California and Oregon, including sites in Santa Clara and Sacramento counties, has joined a global trial of one of the first coronavirus vaccines to begin large-scale testing in humans, the health care provider announced Wednesday. (Allday, 8/12)

In other vaccine news —

ABC News: COVID-19 Vaccine May Be Less Effective In Obese People, Experts Warn 

As the world waits for a COVID-19 vaccine, concerns are already rising that it may not work in obese patients, arguably one of the groups that needs it most. More than 1 in 3 Americans is obese, and the Centers for Disease Control and Prevention has said that obese people are among the groups more likely to get sick and die of COVID-19. (Wood, 8/12)

USA Today: COVID Concerns: Doctors Worry As Kids Miss Scheduled Vaccinations

A recent survey serves as a small snapshot of a national problem that some fear may be exacerbated in the fall as children return to school for in-person instruction. The national survey, released Wednesday and conducted by Orlando Health, found the vast majority of parents believe vaccines are the best way to protect their children from infectious diseases, but two-thirds are still nervous to take their kids to their pediatrician’s office due to COVID-19. (Rodriguez, 8/12)

CNN: US Government Slow To Act As Anti-Vaxxers Spread Lies On Social Media About Coronavirus Vaccine 

While anti-vaxxers flood social media with lies about the upcoming coronavirus vaccine -- that it contains monkey brains, that it's a CIA plot to take over the world -- the government's multi-billion-dollar vaccine effort has yet to come up with a public education campaign to counteract that propaganda. "We are behind here," said Dr. Francis Collins, director of the National Institutes of Health. "We haven't done a good job of getting [coronavirus vaccine] information out there." (Cohen and Vigue, 8/12)

In global developments —

The Hill: Russia Says Coronavirus Vaccine Will Be Ready For Doctors In Two Weeks 

Russia said the first batch of its COVID-19 vaccine will be ready for some medics within two weeks, with Kremlin officials on Wednesday rejecting “groundless” concerns from global health experts about the drug’s speedy approval. “It seems our foreign colleagues are sensing the specific competitive advantages of the Russian drug and are trying to express opinions that in our opinion are completely groundless,” Russian Health Minister Mikhail Murashko said, according to Reuters. (Gstalter, 8/12)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF